$197.55
1.180.60%
At Close: -
$197.55
00.00%
After Hours: 4:37 PM EDT
15 minutes delayed
Comments
Loading...
Latest news for AbbVie (NYSE:ABBV) Stock
AbbVie Stock (NYSE: ABBV)
Categories: All
Friday, August 23, 2024
Tuesday, August 20, 2024
Monday, August 19, 2024
Thursday, August 15, 2024
Wednesday, August 14, 2024
Tuesday, August 13, 2024
Monday, August 12, 2024
Friday, August 09, 2024
Wednesday, August 07, 2024
Tuesday, August 06, 2024
Monday, August 05, 2024
Friday, August 02, 2024
Thursday, August 01, 2024
Wednesday, July 31, 2024
Tuesday, July 30, 2024
Friday, July 26, 2024
- AbbVie Wins Analyst Confidence with Q2 Beat, Diverse Portfolio Fuels Long-Term Growth Expectations
- Cantor Fitzgerald Reiterates Overweight on Ab...
- Lockheed Martin To Rally Over 14%? Here Are 10 Top Analyst Forecasts For Friday
- Truist Securities Reiterates Buy on AbbVie, R...
- Wells Fargo Maintains Overweight on AbbVie, R...
- Barclays Maintains Overweight on AbbVie, Rais...
- AbbVie Gains EU Approval For SKYRIZI To Treat...
Thursday, July 25, 2024
- Stocks Rebound As US Economy Flexes Muscles, Small Caps Rally, Gold Falls: What's Driving Markets Thursday?
- AbbVie shares are trading higher after the co...
- AbbVie's Q2 Earnings Beat Estimates, Raises Annual Profit On Strong Sales From Newer Immunology And Cancer Drugs
- AbbVie Exec Announces Discontinuation Of Furt...
- AbbVie Raises 2024 Adjusted Diluted EPS Guida...
- AbbVie Q2 2024 Adj EPS $2.65 Beats $2.57 Esti...
- Nasdaq, S&P Futures Slide On More Negative Tech Tidings As Focus Shifts To Q2 GDP Data: Strategist Says Trump Trades May Not Work Even If Ex-President Retakes White House